Novo Nordisk in the lead of the Dow Jones Sustainability Index
With 86 out of 100 percent, Novo Nordisk improves its score in the Dow Jones Sustainability Index announced by Sustainable Asset Management (SAM) on 8 September, 2011. Novo Nordisk’s 2010 score was 84. For 2011, the average score for companies in the Healthcare sector is 53.
SAM's analysis measures the performance of leading sustainability-driven companies.
“We are proud to demonstrate continued progress in our overall score, and we’re particularly pleased to see progress in innovation management and customer relationship management which are key business priorities,” says Susanne Stormer, Vice President for Global Triple Bottom Line Management in Novo Nordisk.
Novo Nordisk's total scores in each performance dimension are:
- Economic dimension: 83 compared to the sector average of 60
- Environmental dimension: 92 compared to the sector average 52
- Social dimension: 86 compared to the sector average of 47
In seven categories, Novo Nordisk achieved the best score in the pharmaceuticals sector:
- Customer relationship management
- Human capital development
- Social reporting
- Stakeholder engagement (maximum score 100 percent)
- Bioethics (maximum score 100 percent)
- Addressing cost burden (maximum score 100 percent)
- Climate strategy (maximum score 100 percent)
See Novo Nordisk's complete DJSI score here.
About the Dow Jones Sustainability Indexes
The Dow Jones Sustainability Indexes were launched in 1999. The indexes track the stock performance of the world's leading companies in terms of economic, environmental and social criteria. The indexes serve as benchmarks for investors who integrate sustainability considerations into their portfolios, Read more about the Dow Jones Sustainability Index here.